VEGFA and neoplasm: The combination appears to target two mechanisms that suppress anti-tumor immunity; blocking the PD-1/L1 axis, in tandem with increased immune infiltration and inflammation induced by VEGF axis inhibition, leads to a fully integrated anti-tumor immune response.